IN-VITRO ACTIVITIES OF BETA-LACTAM-BETA-LACTAMASE INHIBITOR COMBINATIONS AGAINST STENOTROPHOMONAS-MALTOPHILIA - CORRELATION BETWEEN METHODSFOR TESTING INHIBITORY ACTIVITY, TIME-KILL CURVES, AND BACTERICIDAL ACTIVITY
Jlm. Bellido et al., IN-VITRO ACTIVITIES OF BETA-LACTAM-BETA-LACTAMASE INHIBITOR COMBINATIONS AGAINST STENOTROPHOMONAS-MALTOPHILIA - CORRELATION BETWEEN METHODSFOR TESTING INHIBITORY ACTIVITY, TIME-KILL CURVES, AND BACTERICIDAL ACTIVITY, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2612-2615
The activities of ampicillin, ampicillin-sulbactam, amoxicillin, amoxi
cillin-clavulanic acid, ticarcillin, ticarcillin-clavulanic acid, pipe
racillin, piperacillin-tazobactam, aztreonam, and aztreonam-clavulanic
against Stenotrophomonas maltophilia strains for which the MICs of pe
nicillins and commercially available beta-lactam-beta-lactamase inhibi
tor combinations were higher than the breakpoints usually recommended
for Pseudomonas aeruginosa in commercially available broth microdiluti
on methods were tested by the agar diffusion, agar dilution, and broth
microdilution methods. Time-kill curve studies were performed when di
screpancies between these methods were observed. The MICs obtained by
the commercially available broth microdilution method, the agar diluti
on method, and the broth microdilution method were almost identical. T
wenty-five percent of the strains tested showed inhibition diameters o
f greater than or equal to 15 mm for ticarcillin-clavulanic acid, and
43.7% of the strains tested showed inhibition diameters of greater tha
n or equal to 18 mm for piperacillin-tazobactam by the agar diffusion
method. The time-kill curves for these strains confirmed the results o
btained by dilution methods. Aztreonam-clavulanic acid (2:1) at concen
trations of less than or equal to 16 mu g/ml inhibited all of these st
rains (MIG range, 1 to 16 mu g/ml). The time-kill curves confirmed thi
s activity. The addition of piperacillin to this combination did not m
odify the MICs. The combination aztreonam-clavulanic acid-ticarcillin
was two-to fourfold more active than aztreonam-clavulanic acid alone.
We studied the inhibitory and bactericidal activities of the two most
active combinations (aztreonam-clavulanic acid and aztreonam-clavulani
c acid-ticarcillin) against the standard inoculum and 10 and 50 times
the standard inoculum. Inoculum modifications did not modify the MICs.
Both combinations showed good bactericidal activity against the stand
ard inoculum. With 10 times the standard inoculum, minimum bactericida
l concentration (MBC) results were heterogeneous (for 55% of the strai
ns, MBCs were between the MIC and 4-fold the MIG, and for 45% of the s
trains MBCs were between 8- and >32-fold the MIG). With 50 times the s
tandard inoculum, MBCs were at least 32-fold the MICs for all the stra
ins tested.